5Mendall MA,Patel P,Ballam L,et al.C reactive protein and its relation to cardiovascular risk factors:a population based cross sectional study[J].BMJ,1996,312:1061-1065. 被引量：1
6Gerstein HC,Mann JF,Pogue J.Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study.The HOPE Study Investigators[J].Diabetes Care,2000,23(Suppl 2):B35-39. 被引量：1
8Lenfant C,Chobanian AV,Jones DW,et al.Seventh report of the Joint National Committee on the Prevention,Detection,Evaluation,and Treatment of High Blood Pressure (JNC 7):resetting the hypertension sails[J].Hypertension,2003,41:1178-1179. 被引量：1
9Chaturvedi S.The Seventh Report of the Joint National Committee on Prevention,Detection,Evaluation,and Treatment of High Blood Pressure (JNC 7):is it really practical[J]? Natl Med J India,2004,17:227-229. 被引量：1
5Psaty BM,Smith NL,Siscovick DS,et al.Health outcomes associated with antihypertensive therapies used as first-line agents[J].JAMA,1997,277:739-745 被引量：1
6Curb D,Pressel SL,Cutler JA,et al.Effect of diuretic-based antihypertensive treatment on cardiovascular diseased risk in older diabetic patients with isolated systolic hypertension[J].JAMA,1996,276(23):1886-1892 被引量：1
7Pasty BM,Lumley T,Furberg CD,et al.Health outcomes associated with various antihypertensive therapies used as first-line agents:a network Meta-analysis[J].JAMA,2003,289(19):2534-2544 被引量：1
8Mimran A.The antihypertensive action of indapamide:results of a French multicentre study of 2184 ambulant patients[J].Postgra Med J,1981,57(l2):60 被引量：1
9Weidmann P.Metabolic profile of indapamide sustained-released in patients with hypertension:data from three randomized double-blind studies[J].Drug Saf,2001,24(15):1155-1165 被引量：1
10Laurent S.Clinical benefit of very-low-dose perindopril-indapamide combination in hypertension[J].J Hypertens Suppl,2001,19(4):S9-14 被引量：1
